Houston Personal Injury Blog
Erin Copeland Appointed Federal-State Liaison, Member of Plaintiffs' Steering Committee for Onglyza MDL

10 Sep. 2018

Erin Copeland Appointed Federal-State Liaison, Member of Plaintiffs' Steering Committee for Onglyza MDL

Posted By Fibich, Leebron, Copeland & Briggs

Fibich, Leebron, Copeland & Briggs Partner Erin Copeland has been appointed to serve in important leadership positions for the Onglyza multidistrict litigation (MDL) pending in the U.S. District Court for the Eastern District of Kentucky.

Onglyza and Kombiglyze XR (Saxagliptin) are drugs intended to improve blood sugar control for Type 2 diabetes. In a major study conducted by the drugs’ very own makers, it was shown that people taking saxagliptin were at a significantly higher risk of developing new onset heart failure requiring hospitalization and, in some instances, resulting in death. Despite these findings, the drug makers failed to adequately include such warnings until they were forced to do so by the FDA.

In February 2018, the United States Judicial Panel on Multidistrict Litigation (JPML) established an MDL for Onglyza and Kombiglze XR cases. Last week, Judge Karen Caldwell, Chief Judge for United States District Court for the Eastern District of Kentucky who is overseeing the MDL, appointed attorney Erin Copeland the Federal-State Court liaison for cases pending in both state courts and the MDL. Attorney Erin Copeland was also appointed to the Plaintiffs’ Steering Committee.

Erin’s appointments in the Onglyza MDL are a testament to her extensive experience with cases involving pharmaceutical injuries, her leadership roles in other major litigation and MDLs (including Essure, Pradaxa, and transvaginal mesh), and her passion for protecting the rights of individuals and families who find themselves facing legal battles against some of the largest pharmaceutical giants and corporate powers in the world.

Our firm congratulates Erin on her recent appointments, where she will make an invaluable contribution to the fight for justice. If you have a potential case involving injuries, death, or losses caused by Onglyza and Kombiglyze XR or any other unsafe medication, Erin and our legal team have a demonstrated record of success and leadership in these matters, and are readily available to help you learn more about your rights. Contact us to speak with an experienced injury attorney.

Categories: Personal Injury
Blog Home

Advantages of Working with Board Certified Attorneys

Our firm is proud to have three lawyers on our team who are board certified by the Texas Board of Legal Specialization. Tommy Fibich is a board certified civil trial law specialist, and Russell Briggs and Jay Henderson are board certified personal injury trial law specialists. Board certification is a great honor-in fact-only 10% of practicing attorneys in the state have earned the right to be publicly recognized as certified specialists in their respective fields.